European Coding System Looks to Combat Counterfeits: Part Two

This is the conclusion of our interview with Anthony Barron, the European Federation of Pharmaceutical Industries and Associations’ (EFPIA) coding and identification project coordinator, who spoke with us about a tracking pilot project currently underway in Sweden aimed at reducing the risk of counterfeit drugs dispensed to patients. Read part one of the interview. PSM:…

[...]

European Coding System Looks to Combat Counterfeits: Part One

In October 2009, the European Federation of Pharmaceutical Industries and Associations (EFPIA) announced its pilot project—a coding system aimed at reducing the risk of counterfeit drugs dispensed to patients. The project entails the use of a small barcode to verify individual packs of medicine, aiming for an end-to-end tracking, which allows the pack to be…

[...]

Who is PharmacyChecker? Checking the Facts on PharmacyChecker.com

Who is PharmacyChecker.com? PharmacyChecker is a company that provided online pharmacy certification services for the major search engines until 2010. Why did the search engines stop using PharmacyChecker’s services? None of the search engines gave a public reason for ending their relationship with PharmacyChecker.  Several experts in the field, including our own Bryan Liang, criticized…

[...]

International Consortium Tackles Global Counterfeit Problem: Part Two

Last week, we brought you part one of our interview with Martin VanTrieste, vice president of quality assurance at Amgen, a biotechnology company, and the co-founder of Rx-360, a global consortium formed to address weaknesses in the pharmaceutical supply chain. Now we bring you the conclusion of our interview. PSM: It might surprise some that…

[...]

International Consortium Tackles Global Counterfeit Problem:
Part One

From drug manufacturing to delivery, weaknesses in the pharmaceutical supply chain have been long documented—and introduce opportunities for substandard and counterfeit medications to be passed along to consumers. To mitigate this global threat, a group of companies and associations from all facets of the pharmaceutical industry have teamed up to form Rx-360, an international consortium…

[...]